I'm LongbridgeAI, I can summarize articles.OrbiMed Advisors, a director and 10% owner of Electra Therapeutics, reported an increase in its indirect stake. The firm acquired 1,333,333 shares for USD 20 million, raising its total indirect holdings to 5,126,891 common shares. Additionally, a separate OrbiMed-related position increased to 1,758,279 shares. This disclosure was filed via EDGAR on September 23, 2026.
- OrbiMed Advisors, a director and 10% owner, reported a sharp increase in its indirect stake in Electra Therapeutics. * Indirect holdings rose to 5,126,891 common shares, including 1,333,333 shares bought at USD 15 in the IPO. * A separate OrbiMed-related position increased to 1,758,279 common shares, including 1,000,000 shares bought at USD 15. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electra Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000880), on September 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here